![](/img/cover-not-exists.png)
A Phase 2, Randomized, Dose-Response Trial of Taprenepag Isopropyl (PF-04217329) Versus Latanoprost 0.005% in Open-Angle Glaucoma and Ocular Hypertension
Schachar, Ronald A., Raber, Susan, Courtney, Rachel, Zhang, MinVolume:
36
Language:
english
Journal:
Current Eye Research
DOI:
10.3109/02713683.2011.593725
Date:
September, 2011
File:
PDF, 601 KB
english, 2011